Long-term survival in 618 patients from the Western Washington streptokinase in myocardial infarction trials
- 31 December 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (7), 1452-1459
- https://doi.org/10.1016/0735-1097(92)90436-q
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Risk stratification before thrombolytic therapy in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1990
- Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the NetherlandsJournal of the American College of Cardiology, 1989
- Characteristics associated with early (≤ 3 months) versus late (> 3 months to ≤ 3 years) mortality after acute myocardial infarctionThe American Journal of Cardiology, 1989
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Improved survival up to four years after early coronary thrombolysisThe American Journal of Cardiology, 1988
- Relative prognostic value of rest thallium-201 imaging, radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring after acute myocardial infarctionJournal of the American College of Cardiology, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983